| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 713664 | Null | 0.0280810439814509 | -0.33248443 |
| NSC 723397 | Null | 0.0280810439814509 | 0.24009559 |
| NSC 723565 | Null | 0.0280810439814509 | 0.10943181 |
| NSC 732568 | 6,8-Dibromo-2-phenyl-3-[5?-amino6?(2??,3??-dichlorophenyl)1, 2,4-triazin-3-yl]quinazolin-4(3H)-one (SPC-IIIBr) | 0.0280810439814509 | 0.10162744 |
| NSC 741440 | 3,3?-furan-2,5-diylbis(5-methoxy-1-methyl-1H-indole) | 0.0280810439814509 | 0.099546935 |
| NSC 741909 | 1H-Indole-3-methanol, 1-[(4-chlorophenyl)methyl]- | 0.0280810439814509 | 0.030803007 |
| NSC 750717 | 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one | 0.0280810439814509 | 0.21502302 |
| NSC 753575 | N1-(1,3-benzothiazol-2-yl)-2-{2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxy}acetamide | 0.0280810439814509 | 0.18395291 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0303734648501639 | 0.1932327 |
| NSC 157381 | Null | 0.0303734648501639 | 0.17476548 |